Artwork

Content provided by The Deadly Dose, Harini Bhat, and Megan Gesner. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Deadly Dose, Harini Bhat, and Megan Gesner or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep 119 - Ozempic: No Longer Hot Right Now

1:24:12
 
Share
 

Manage episode 367972616 series 2841142
Content provided by The Deadly Dose, Harini Bhat, and Megan Gesner. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Deadly Dose, Harini Bhat, and Megan Gesner or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In today's episode, Megan provides a step-by-step update on her compounded semaglutide journey. She and Harini also contemplate the quick but quiet death of the Ozempic craze (at least by frenzied-netizen-discourse standards). Why were we all so passionately opiniated about Ozempic for five months, and now can barely get DailyMail to cover it? And what has the FDA had to say since the Ozempic name has become passé? Tune in to find out!

NOTE: Since the recording of this episode, the American Diabetes Association has released new data on a wide-array of novel GLP-1 agonists ("obesity drugs") that truly make semaglutide old news. Read about it here: https://www.theatlantic.com/health/archive/2023/06/ozempic-pills-obesity-drugs-semaglutide/674541/

See omnystudio.com/listener for privacy information.

  continue reading

101 episodes

Artwork
iconShare
 
Manage episode 367972616 series 2841142
Content provided by The Deadly Dose, Harini Bhat, and Megan Gesner. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Deadly Dose, Harini Bhat, and Megan Gesner or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In today's episode, Megan provides a step-by-step update on her compounded semaglutide journey. She and Harini also contemplate the quick but quiet death of the Ozempic craze (at least by frenzied-netizen-discourse standards). Why were we all so passionately opiniated about Ozempic for five months, and now can barely get DailyMail to cover it? And what has the FDA had to say since the Ozempic name has become passé? Tune in to find out!

NOTE: Since the recording of this episode, the American Diabetes Association has released new data on a wide-array of novel GLP-1 agonists ("obesity drugs") that truly make semaglutide old news. Read about it here: https://www.theatlantic.com/health/archive/2023/06/ozempic-pills-obesity-drugs-semaglutide/674541/

See omnystudio.com/listener for privacy information.

  continue reading

101 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide